search_icon 

close_icon

search_icon  

search_icon  

Current EU-Projects 

 

EU - Horizon 2020 - ERC-2017
Projects coordinated by MUI

EPIC
Enabling Precision Immuno-oncology in Colorectal cancer
Coordinator: Univ.-Prof. Dipl.-Ing. Dr. Zlatko Trajanoski, Division of Bioinformatics
Duration: 01.10.2018 – 30.09.2023

HOPE
Host Protective Engineering of Cancer Immunity by Targeting the Intracellular Immune Checkpoint NR2F6
Coordinator: Univ.-Prof. Dr. Gottfried Baier, Division of Cell Genetics
Duration: 01.10.2018 – 30.09.2023

POLICE
The PIDDosome in Centrosome and Ploidy-Surveillance
Coordinator: Univ.-Prof. Mag. Dr. Andreas Villunger, Division of Developmental Immunology
Duration: 01.10.2018 – 30.09.2023

EU - Horizon - ERC-2021
Projects coordinated by MUI

MEGI CD
MEtabolic Gut Inflammation in Crohn's Disease
Coordinator: Assistenzprofessor Dr. Timon Adolph PhD, University Hospital for Internal Medicine I
Duration: 01.04.2022 - 31.03.2027

Horizon 2020
Project coordinated by MUI
DC-Ren
Drug combinations for rewriting trajectories of renal pathologies in type II diabetes
Coordinator: Univ.-Prof. Dr. Gert Mayer, University Hospital for Internal Medicine IV
Duration: 01.01.2020 – 31.12.2024

Projects in Horizon 2020
Projects with participation of MUI
ACTRIS IMP
Aerosol, Clouds and Trace Gases Research Infrastructure Implementation Project
Partner: Dr. Jochen Wagner, Institute of Biomedical Physics
Duration: 01.01.2020 – 31.12.2023

Alternative
environmentAL Toxicity chEmical mixtuRes through aN innovative platform based on aged cardiac tissue model
Partner: Dipl.-Ing. Dr. Martin Paparella, Institute of Medical Biochemistry
Duration: 01.10.2021 - 14.06.2022

ATMO ACCESS
Solutions for Sustainable Access to Atmospheric Research Facilities
Partner: Dr. Jochen Wagner, Institute of Biomedical Physics
Duration: 01.04.2021 – 31.12.2023

CleanAir
Lab to Fab development of air decontamination system for protecting health practitioners against COVID19
Partner: Dr. Alexandra Kimpel, Institute of Virology
Duration: 23.03.2021 - 31.10.2022

EHVA
European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates
Partner: Univ.-Prof. Dr. Dorothee von Laer, Division of Virology
Duration: 01.01.2016 – 30.06.2023

FAIR-PARK-II
Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone
Partner: o. Univ.-Prof. Dr. Werner Poewe, University Hospital for Neurology
Duration: 01.05.2015 – 31.10.2021

HBP-SGA3
Human Brain Project Specific Grant Agreement 3
Partner: Dipl.-Ing. Tina Kokan, University Hospital for Psychiatry I
Duration: 01.04.2020 – 31.03.2023

INCITE
Immune Niches for Cancer ImmonoTherapy Enhancement
Partner: Univ.-Prof. Dipl.-Ing. Dr. Zlatko Trajanoski, Institute of Bioinformatics
Duration: 01.05.2021 – 30.04.2025

KidsAP
The artificial pancreas in children aged 1 to 7 years with type 1 diabetes
Partner: Assoz. Prof. Priv.-Doz. Dr. Sabine Hofer,
University Hospital for Paediatrics I
Duration: 01.01.2017 – 31.12.2021

MESI-STRAT
Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patients Stratification
Partner: Univ.-Prof. Dr. Christian Marth, University Hospital for Gynaecology and Obstetrics
Duration: 15.07.2020 – 30.09.2022

PRISMAP
The European medical isotope programme: Production of high purity isotopes by mass separation
Partner: Univ.-Doz. Mag. Dr. Clemens Decristoforo, University Hospital for Nuclear Medicine
Duration: 01.05.2021 – 26.11.2022

SAND
Secretion, Autophagy and their role in Neurodegeneration
Partner: Univ.-Prof. Dr. Farhan Hesso, Institute of Pathophysiology
Duration: 01.01.2021 – 31.10.2023

STEFA – ISFP-Grant
Steps Towards a European Forensic Science Area
Partner: o. Univ.-Prof. Dr. Richard Scheithauer, Institute of Forensic Medicine
Duration: 01.01.2018 – 31.12.2020

Tension
Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial
Partner: Univ.-Prof. Dr. Elke Ruth Gizewski MHBA, University Hospital for Neuroradiology
Duration: 01.01.2018 – 30.06.2023

TTV GUIDE TX
Personalisation of immunosuppression by monitoring viral load post kidney transplantation – a randomized controlled phase II trial
Partner: Assoz. Prof. Priv.-Doz. Dr. Hannes Neuwirt, University Hospital for Internal Medicine IV
Duration: 01.05.2021 – 30.04.2026

VISAGE
Broadened Forensic Use of DNA for Constructing Composite Sketches from Traces
Partner: ao. Univ.-Prof. Mag. Dr. Walther Parson, Institute of Forensic Medicine
Duration: 01.05.2017 – 31.10.2021

EU ISF
INFER
Introduction of forensic genomic tools for estimating Appearance, Ancestry and Age
Coordinator: o. Univ.-Prof. Dr. Richard Scheithauer, Institute of Forensic Medicine
Duration: 01.09.2019 – 28.02.2022

Marie Skłodowska-Curie Actions
Projects coordinated by MUI
CORVOS
COmplement Regulation and Variation in Opportunistic infectionS
Coordinator: Ao. Univ.-Prof. Dr. Reinhard Würzner, Division of Hygiene and Medical Microbiology
Duration: 01.12.2019 – 30.11.2023

Projects with participation of MUI
TOBEaTPAIN
Targeting neuroinflammation to combat pathological pain in neurodegenerative diseases and chronic pain syndromes
Partner: Univ.-Prof. Dr. Michaela Kress, Institute of Physiology
Duration: 01.08.2018 – 31.07.2022

SECRET
Exploitation of the SECRETory pathway for cancer therapy to address European research
Partner: Univ.-Prof. Dr. Farhan Hesso, Institute of Pathophysiology
Duration: 01.01.2021 – 30.09.2023

Marie Skłodowska-Curie Research and Innovation Staff Exchange
OCSEAN
OCeanic and South East Asian Navigators
Partner: o. Univ.-Prof. Dr. Richard Scheithauer, ao. Univ.-Prof. Dr. Walther Parson, Institute of Forensic Medicine
Duration: 01.01.2020 – 31.12.2023

H2020 – Cofund EJP (European Joint Programme)
HBM4EU
European Human Biomonitoring Initiative
Partner: Assoz. Prof. Priv.-Doz. Mag. Dr. Herbert Oberacher, Institute of Forensic Medicine
Duration: 01.01.2017 – 30.06.2022

Projects in FP7
Large-scale integrating projects
Small or medium-scale focused research project
Projects coordinated by MUI
GANNET53
A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer
Coordinator: Univ.-Prof. Dr. Nicole Concin, University Hospital for Gynaecology and Obstetrics
Duration: 01.10.2013 – 31.12.2020

IMI – Innovative Medicines Initiative
BEAt-DKD
Biomarker Enterprise to Attack DKD
Partner: Univ.-Prof. Dr. Gert Mayer, University Hospital for Internal Medicine IV
Duration: 01.09.2016 – 31.08.2023

imSAVAR
Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
Partner: Univ.-Prof. Dipl.-Ing. Dr. Zlatko Trajanoski, Institute of Bioinformatics
Duration: 01.12.2019 – 30.11.2025

IDEA-FAST
Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivitiesdaily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases
Partner: Univ.-Prof. Dr. Klaus Seppi, University Hospital for Neurology
Duration: 01.11.2019 – 30.04.2025

SISAQOL
Setting International Standards of Patient-Reported Outcomes and Quality of Life Endpoints Data in Cancer Clinical Trials
Partner: Univ.-Prof. Dr. Bernhard Holzner, Priv.-Doz. Dr. Johannes Giesinger, University Hospital for Psychiatry II
Duration: 01.01.2021 – 31.12.2024

FWF-EU
ERA; E-RARE-3 2016
Efficacy and safety of nicotinamide in patients with Friedreich´s ataxia (NICOFA)
Coordinator: Priv. Doz. Dr. Sylvia Bösch, University Hospital for Neurology
Duration: 01.04.2017 – 31.03.2022

ERA; ERA-CVD 2018
Investigating long non-coding RNA regulated pathways (INNOVATION)
Coordinator: Dr. Bernhard Haubner, PhD, University Hospital for Internal Medicine I
Duration: 01.04.2019 – 05.10.2022

ERA; PERMED 2018
Novel 99mTc-labeled somatostatin receptor antagonists (TECANT)
Coordinator: Univ.-Prof. Dr. Irene Virgolini, University Hospital for Nuclear Medicine
Duration: 01.07.2019 – 30.06.2023

ERA; PERMED 2018
Biomolecular Analyses for Tailored Medicine in AcneiNversa (BATMAN)
Coordinator: Univ.-Prof. Dr. Matthias Schmuth, University Hospital for Dermatology, Venerology and Allergology
Duration: 01.05.2019 – 30.04.2023

ERA; PERMED 2018
Personalized Treatment in IgA Nephrpopathy (PersTIgAN)
Coordinator: Dr. Michael Rudnicki, University Hospital for Internal Medicine IV
Duration: 01.05.2019 – 30.04.2022

ERA; PERMED 2021
BRAVA - Behaviours in REM sleep: personalised Automatic 3D Video Analysis as novel tool to detect alpha-synucleinopathies
Coordinator: Univ.-Prof. Dr Birgit Högl, University Hospital for Neurology
Duration: 01.04.2022 - 30.03.2025

INTERREG Italia – Österreich
P-CARE - Eine technologische Plattform zur Bekämpfung von Krebstherapieresistenzen
Coordinator: Univ.-Prof. Dr. Dominik Wolf, University Hospital for
Internal Medicine V
Duration: 01.10.2019 – 31.06.2022

InCardio – Innovative Therapien zur Behandlung kardiovaskulärer Erkrankungen
Coordinator: Assoz. Prof. Priv.-Doz. Dr. Manuel Maglione, MBA, University Hospital for Visceral, Transplant and Thoracic Surgery
Duration: 01.11.2020 – 31.10.2022

EU-Projects finished

 

aktualisiert 16.05.2022